Ely Benaim

Companies

• NovoCure LtdChief Medical Officer Aug 1, 2019 to Jan 10, 2023¹
• Opus Genetics, Inc.Chief Medical Officer Feb 4, 2015 to Mar 1, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NNovoCure Ltd NVCR28,770 shares³$414.6K at $14.41Jan 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 6, 2023Granted 98 shares at $62.31 of NovoCure Ltd³
• Aug 3, 2022Sold 5,396 shares at $74.00 of NovoCure Ltd⁴
• Aug 3, 2022Sold 563 shares at $71.09 of NovoCure Ltd⁴
• Aug 2, 2022Sold 437 shares at $69.66 of NovoCure Ltd⁵
• Jul 5, 2022Granted 222 shares at $59.08 of NovoCure Ltd⁶
• May 11, 2022Sold 2,135 shares at $61.25 of NovoCure Ltd⁷
• May 10, 2022Sold 2,070 shares at $65.16 of NovoCure Ltd⁷
• Mar 4, 2022Sold 1,510 shares at $70.41 of NovoCure Ltd⁸
• Mar 3, 2022Sold 803 shares at $74.50 of NovoCure Ltd⁸
• Mar 3, 2022Granted 17,371 shares of NovoCure Ltd⁸
• Jan 6, 2022Granted 55 shares at $63.82 of NovoCure Ltd⁹